Home/Filings/4/0001104659-18-005845
4//SEC Filing

Foster Wayne 4

Accession 0001104659-18-005845

CIK 0001442836other

Filed

Jan 31, 7:00 PM ET

Accepted

Feb 1, 4:01 PM ET

Size

18.2 KB

Accession

0001104659-18-005845

Insider Transaction Report

Form 4
Period: 2018-01-30
Foster Wayne
Vice President of Finance
Transactions
  • Exercise/Conversion

    Common Stock

    2018-01-30$1.53/sh+8,055$12,32465,322 total
  • Exercise/Conversion

    Common Stock

    2018-01-30$1.62/sh+889$1,44057,267 total
  • Exercise/Conversion

    Option to Purchase Common Stock

    2018-01-30889889 total
    Exercise: $1.62Exp: 2024-12-15Common Stock (889 underlying)
  • Exercise/Conversion

    Option to Purchase Common Stock

    2018-01-308,05512,084 total
    Exercise: $1.53Exp: 2025-06-11Common Stock (8,055 underlying)
  • Exercise/Conversion

    Option to Purchase Common Stock

    2018-01-302,49910,834 total
    Exercise: $6.98Exp: 2027-03-13Common Stock (2,499 underlying)
  • Exercise/Conversion

    Common Stock

    2018-01-30$4.10/sh+3,262$13,37468,584 total
  • Exercise/Conversion

    Common Stock

    2018-01-30$6.98/sh+2,499$17,44371,083 total
  • Exercise/Conversion

    Option to Purchase Common Stock

    2018-01-303,2628,155 total
    Exercise: $4.10Exp: 2026-08-29Common Stock (3,262 underlying)
Footnotes (4)
  • [F1]The original option grant for 3,555 option shares vests in equal quarterly installments over the first four years after the vesting commencement date, January 2, 2015.
  • [F2]The original option grant for 32,222 option shares vests in equal quarterly installments over the first four years after the vesting commencement date, June 12, 2015.
  • [F3]The original option grant for 13,047 option shares vests in equal quarterly installments over the first four years after the vesting commencement date, July 1, 2016.
  • [F4]The original option grant for 13,333 option shares vests in equal quarterly installments over the first four years after the vesting commencement date, March 14, 2017.

Documents

1 file

Issuer

Mersana Therapeutics, Inc.

CIK 0001442836

Entity typeother

Related Parties

1
  • filerCIK 0001709769

Filing Metadata

Form type
4
Filed
Jan 31, 7:00 PM ET
Accepted
Feb 1, 4:01 PM ET
Size
18.2 KB